Partnership research

DEINOVE, a French biotech company that uses a disruptive approach to develop innovative antibiotics and bio-based active ingredients for cosmetics and nutrition, has announced that it will benefit from the Institut Pasteur's provision of biological resources for the research of new antimicrobial agents from original strains. The Institut Pasteur (Pasteur MS Carnot Institute), one of the most renowned worldwide players in the area of infectious disease research, will entrust a targeted selection of strains from their bacterial collection to DEINOVE.

Curie Cancer Carnot Institute and Freenome announce a strategic collaboration to evaluate Freenome’s artificial intelligence (AI) genomics platform as a novel tool to predict patient response to immuno-oncology therapies by observing changes in circulating cell-free biomarkers.

The Carnot Insitute CALYM obtained the renewal of its ISO 9001 certification for the management and monitoring of its research activities and the coordination of its CeVi collection of lymphoma viable cells. Particularity of this year, the changeover to the 2015 version.

CALYM’s 3rd SCIENTIFIC & PARTNERING DAY, will take place next October 17, 2016 in Paris, Espace Van Gogh, 62, quai de la Rapée.
CALYM researchers and clinicians will be happy to present the new lymphoma R&D offering and highlight research results of the consortium, from new therapeutic targets identification to Phase III pivotal clinical trials and beyond.
IPSEN and CELGENE representatives will bring industry standpoint.

Download the program